35.3

35.30 (0.75%)

As of Mar 01, 2024

Immunovant, Inc. [IMVT]

Source: 

Company Overview

Immunovant, Inc is a clinical-stage biopharmaceutical company dedicated to enabling normal lives for people with autoimmune diseases. We were incorporated in Delaware in December 2018 as a blank check company under the name Health Sciences Acquisitions Corporation (“HSAC”).

CountryUS
Headquartersnew yorknew york
Phone Number(917) 580-3099
Industrybiological products (no diagnostic substances)
CEOPeter Salzmann
Websiteimmunovant.com